Turning the world of drugs upside down
When Abbas Hussain was recruited by GlaxoSmith-Kline’s chief executive Andrew Witty last year to head emerging markets, the idea was to shift the pharmaceutical company away from ‘white pills in western markets’
source : traxfer.ft.com
Related News:
- Tuberculosis advance: Existing drugs can potentially target the disease’s capability to spread
- Certain Epilepsy Drugs May Increase Risk Of Suicide
- Bones May Hold Key to New Diabetes Drugs
- Avandia fraud explained: Why Big Pharma keeps lying about its drugs (opinion)
- New way to target viruses could make antiviral drugs more effective
- Cancer drugs may help stop major parasite
- Discovery That Sirtuin1 May Boost Memory And Learning Ability Could Lead To New Drugs To Fight Alzheimer’s, Other Neurological Diseases
- NICE Concerned Over Bone Cancer Drug’s Level Of Efficacy And High Cost In Draft Guidance
- FDA grants unsafe drugs to be fed to livestock
- ADA: Safety Key to Developing Diabetes Drugs
Details :
Submited at Sunday, November 29th, 2009 at 7:00 pm on Pharmaceutical by Alina
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...